Kwality Pharmaceuticals Limited (BOM:539997)

Kwality Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 16, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	12,082	9,017	4,248	3,191	6,018	581
Market Cap Growth	112.27%	112.27%	33.12%	-46.97%	935.71%	119.18%
Enterprise Value	13,042	9,948	5,076	4,145	6,180	772
Last Close Price	1164.40	869.05	409.40	307.55	580.00	56.00
PE Ratio	30.35	22.63	17.85	16.47	5.02	3.84
PS Ratio	3.26	2.44	1.38	1.27	1.32	0.22
PB Ratio	4.60	3.44	1.91	1.60	3.35	0.97
P/TBV Ratio	4.61	3.44	1.90	1.59	3.32	0.95
P/FCF Ratio	41.06	30.65	32.33	-	110.54	17.58
P/OCF Ratio	22.92	17.11	9.88	7.71	9.93	2.18
EV/Sales Ratio	3.52	2.69	1.65	1.65	1.36	0.29
EV/EBITDA Ratio	15.85	12.09	7.46	6.73	3.56	2.56
EV/EBIT Ratio	20.37	15.54	10.48	8.88	3.80	3.26
EV/FCF Ratio	44.32	33.81	38.62	-	113.51	23.35
Debt / Equity Ratio	0.43	0.43	0.44	0.45	0.35	0.69
Debt / EBITDA Ratio	1.37	1.37	1.44	1.46	0.36	1.37
Debt / FCF Ratio	3.82	3.82	7.47	-	11.61	12.47
Asset Turnover	0.88	0.88	0.82	0.72	1.80	1.76
Inventory Turnover	2.26	2.26	1.92	1.63	4.88	5.75
Quick Ratio	1.00	1.00	0.90	0.68	0.65	0.59
Current Ratio	1.67	1.67	1.60	1.65	1.63	1.35
Return on Equity (ROE)	16.41%	16.41%	11.20%	10.18%	100.10%	28.41%
Return on Assets (ROA)	9.51%	9.51%	8.10%	8.40%	40.13%	9.90%
Return on Capital (ROIC)	11.51%	11.51%	9.93%	10.96%	59.11%	16.36%
Return on Capital Employed (ROCE)	23.00%	23.00%	20.00%	20.50%	80.90%	26.90%
Earnings Yield	3.30%	4.42%	5.60%	6.07%	19.94%	26.07%
FCF Yield	2.44%	3.26%	3.09%	-1.97%	0.91%	5.69%
Buyback Yield / Dilution	-0.11%	-0.11%	-	-	-0.00%	-
Total Shareholder Return	-	-0.11%	-	-	-0.00%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.